CRO概念股震荡走低，奥翔药业跌超8%

Core Viewpoint - The CRO (Contract Research Organization) sector is experiencing a decline in stock prices, with significant drops observed in several companies [1] Group 1: Company Performance - Aoshang Pharmaceutical has seen its stock price drop by over 8% [1] - Hite Bio has experienced a decline of more than 6% [1] - Other companies such as Meinohua, Zhaoyan New Drug, and Tiger Medical are also following the downward trend [1]